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Prevention is a promising option for the control of cancer. Cellular redox changes have emerged as a pivotal and proximal event in
cancer. In this review, we provide a brief background on redox biochemistry, discuss the important distinction between redox
signalling and oxidative stress, and outline the ‘multiple biological personalities’ of reactive oxygen and nitrogen species: at low
concentrations they protect the cell; at higher concentrations they can damage many biological molecules, such as DNA, proteins,
and lipids; and, as we argue here, they may also prevent cancer by initiating the death of the transformed cell. Nitric oxide-donating
aspirin is discussed as an instructive example: it generates a state of oxidative stress through which it affects several redox-sensitive
signalling pathways, leading ultimately to the elimination of the neoplastic cell via apoptosis or necrosis. As additional examples, we
discuss the chemopreventive n–3 polyunsaturated fatty acids and conventional nonsteroidal anti-inflammatory drugs, which induce
cell death through redox changes. We conclude that modulation of redox biochemistry represents a fruitful approach to cancer
prevention.
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Prevention has emerged as a promising option for the control of
cancer, a defining medical challenge of our time. The ultimate aim
of prevention is to accomplish one or more of the following three
goals: eliminate the causative agent (e.g., smoking cessation);
remove a precancerous lesion (e.g., endoscopic resection of colon
adenomas); or counteract pathogenetic pathways (e.g., efforts to
prevent cancer using COX-2 inhibitors). Some, although slow,
progress has been achieved with the first two approaches, but to
date mechanism-driven efforts have rendered no major gains.
Work in recent years has generated enhanced appreciation of
the complexity and relevance of pathways altered in the cancer cell.
Cellular redox changes, much more explored in cardiology than in
oncology (Gutierrez et al, 2006), emerge as a pivotal and proximal
event in cancer. Initially thought of as ‘the bad guy’, mainly
because oxidative stress promotes DNA damage, redox changes
may mediate cancer prevention by natural and pharmaceutical
agents. After providing a brief background to redox biochemistry,
we focus on the chemopreventive nitric oxide-donating aspirin
(NO-ASA) to illustrate the concept that altering the redox status of
the cancer cell represents a valid strategy for cancer prevention.
REDOX BIOCHEMISTRY: THE BASICS
Redox biochemistry is fundamental to life. The energy needs of
complex organisms require vast amounts of ATP. The supply of
ATP depends heavily on redox chemistry, as it is driven by changes
in free energy associated with electron or hydrogen transfers (Frein
et al, 2005). Technically, redox, shorthand for reduction/oxidation,
describes all chemical reactions in which the oxidation state of
atoms changes. In simpler terms, oxidation describes the loss of
electrons by a molecule, atom, or ion, with reduction describing the
gain of electrons by the same. Redox signalling is the concept that
electron-transfer processes play a key messenger role in biological
systems. At the heart of redox signalling are the so-called reactive
oxygen species (ROS), a term that includes oxygen radicals (e.g.,
O2
K and OH
K) and also nonradical derivatives of O2 (H2O2). The
discovery of the reactive nitrogen species expanded this term to
reactive oxygen and nitrogen species (RONS) (Table 1). Free
radicals contain one or more unpaired electrons. Since all molecules
seek to be balanced, that is, to have an equal number of protons and
electrons, the unpaired electron spins of these radicals make them
highly reactive.
Reactive oxygen and nitrogen species are produced continu-
ously by the mitochondria (O2
K,H 2O2, and OH
K) of most cells and
also by cytochrome P450 (O2
K and H2O2), macrophages (O2
K,
H2O2, and NO
K), and peroxisomes (H2O2) (Klaunig and Kamen-
dulis, 2004; Genestra, 2007). During mitochondrial oxidative
metabolism about 5% of oxygen is converted primarily into
O2
K, whereas 95% of it is reduced to water. Given the high
reactivity of RONS, it is not surprising that the cell has invested
heavily into an antioxidant defence system to contain RONS. This
defence system includes (a) classic antioxidant enzymes, such as
superoxide dismutase (SOD), catalase, glutathione (GSH) peroxi-
dase, glutaredoxin, and thioredoxin. These enzymes are distributed
in mitochondria, peroxisomes, and cytoplasm. (b) Nonclassic
antioxidant enzymes, for example, haem oxygenase-1. (c) Phase II
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reductase, NQO1, and GSH transferase; and (d) nonenzymatic
antioxidants, such as vitamins E and C, GSH, and catechins.
RONS: THEIR MULTIPLE BIOLOGICAL
PERSONALITIES
For years, the intuitive, although perhaps uncritical, assumption
has been that all RONS are bad for the cell. The consequent
response has been to try to suppress RONS, hoping to prevent
or even reverse RONS-related biological damage. Reactive oxygen
and nitrogen species, however, have what could be termed
‘multiple biological personalities’: at low concentrations they
protect the cell; at higher concentrations they can damage many
biological molecules, such as DNA, proteins, and lipids; and yet, as
we will argue here, they may also help prevent cancer by initiating
the death of the transformed cell.
An important conceptual distinction has become clear in the
past several years (even though adequate terminology has not yet
been proposed) (Frein et al, 2005; Halliwell, 2007). First, there
exists a network of redox-based regulatory mechanisms that are
often quite relevant to carcinogenesis. Second, disturbed redox
equilibrium is pathophysiological, having been described for years
as ‘oxidative stress’. These findings have led to the recent
delineation of redox signalling and oxidative stress. Redox
signalling is a reversible phase of physiological regulatory
reactions occurring over shorter time periods; they concern
primarily the main cellular redox systems, for example, GSH,
ascorbate, vitamin E, lipoic acid, NADPH, or NADH. The oxidative
reactions, leading to posttranslational protein modification, are
returned to the resting state by reductive pathways. Such
modifications include glutathiolation, S-nitrosylation, methionine
sulphoxidation, and oxidations with disulphide formation. In
contrast, oxidative stress denotes a persistent (over longer time
periods) and often irreversible oxidative shift that characterises a
pathophysiological state. It has been defined as an imbalance
between oxidants and antioxidants in favour of the former,
resulting in increased cellular levels of RONS. Oxidative stress is
implicated in the pathogenesis of several diseases such as cancer,
cardiovascular and neurodegenerative disorders, sepsis, reperfu-
sion damage, rheumatoid arthritis, and diabetes.
There is significant, although incomplete, evidence for a role of
RONS in cancer, including genotoxicity, promotion of transformed
cell growth, and angiogenesis as well as regulation of apoptosis. A
‘persistent oxidative stress in cancer’ has been hypothesised, for
example, in Toyokuni et al (1995). Such oxidative stress was
considered to contribute to oncogene activation, genomic in-
stability, chemotherapy resistance, and even invasion and metas-
tasis. Nuclear factor-kB (NF-kB), MAPK cascades as well as GSH
and related antioxidant pathways were hypothesised to be the
mediators. Chronic inflammation, widely connected to carcino-
genesis, is also a source of RONS and a linkage of inflammation-
generated RONS to cancer has also been postulated. The hypoxia-
inducible factor-1a (HIF-1a) is linked to cancer through its
regulation by RONS (Pouyssegur and Mechta-Grigoriou, 2006); in
particular, RONS signalling may account for the high levels of
HIF-1a in normoxic areas of tumours. Hypoxia-inducible factor
promotes survival in low oxygen conditions, like those encoun-
tered in cancer, by upregulating an array of hypoxia-induced
genes, including the vascular endothelial factor, which promotes
angiogenesis. Finally, RONS have been associated with the
induction of apoptotic and necrotic cell death, the specific
outcome depending, among others, on the cellular levels of RONS.
NO-ASA: A CASE OF RONS-MEDIATED CANCER
PREVENTION
Nitric oxide-donating aspirin consists of conventional aspirin to
which the NO-releasing moiety –ONO2 has been attached via a
chemical linker as reviewed in Rigas and Kashfi (2004) (Figure 1).
Studies using animal tumour models have established the strong
chemopreventive effect of NO-ASA against colon and pancreatic
cancer. The remarkably potent inhibition by NO-ASA of the
growth of various human cell lines, for example, colon, prostate,
lung, pancreas, tonsil, breast cancer, and leukaemia, suggests that a
similar chemopreventive effect on these types of malignancies is
also possible.
The growth inhibitory effect of NO-ASA is due to a profound
cytokinetic effect consisting of reduced cell proliferation, enhanced
cell death, and inhibition of cell cycle phase transitions. We have
studied signalling pathways that potentially underlie this effect.
NO-ASA (a) inhibited the activation of NF-kB in various cancer
cell lines and in vivo (Williams et al, 2003); (b) inhibited the
transcriptional activity of b-catenin by diminishing its physical
association with TCF (Nath et al, 2003); (c) increased the
phosphorylation of p38 and JNK, representing two out of the
three main MAPK cascades; its effect on the ERK1/2 pathway was
minimal (Hundley and Rigas, 2006); (d) inhibited both the
catalytic activity and expression of iNOS, the inducible isoform
of nitric oxide synthase (NOS) (Spiegel et al, 2005); (e) had mixed
effects on the COX pathway: it induced the expression of COX-2
(no effect on COX-1) in various cell lines, whereas in animals it
inhibited COX activity and the levels of various prostaglandins
(Williams et al, 2003; Rao et al, 2006); and (f) induced the
translocation of Nrf2 into the nucleus, promoting its dissociation
from its cytoplasmic anchor Keap1 (Gao et al, 2006).
A shared characteristic of these pathways is that they are redox
sensitive or involved in the regulation of the redox status of the
cell. This prompted us to examine whether NO-ASA increased ROS
levels. Both O2
K and a series of RONS collectively assayed by the
DCFDA probe were elevated in response to NO-ASA (Gao et al,
2005); subsequent work has revealed increased intracellular levels
of H2O2, peroxynitrite, and NO (Sun Y, Rigas B, unpublished data).
The oxidative stress that was thus induced led to apoptosis by
activating the intrinsic apoptosis pathway. Pretreatment of the
cells with N-acetylcysteine abrogated cell death and restored cell
growth to control levels, clearly indicating that generating a state
of oxidative stress in the target cells was a critical proximal event
in the action of NO-ASA in cancer. Nitric oxide-donating aspirin
also induced apoptosis in small intestinal cells of Min mice that
Table 1 Reactive oxygen and nitrogen species (RONS)
Reactive oxygen species Reactive nitrogen species
Radicals Nonradicals Radicals Nonradicals
Superoxide (O2
K), hydroxyl
(OH
K), peroxyl (RO2
K), alkoxyl
(RO
K), hydroperoxyl (HO2
K)
Hydrogen peroxide (H2O2),
hypochlorous acid (HOCl), ozone
(O3), singlet oxygen (
1DgO2),
peroxynitrite (ONOO
)
Nitric oxide (NO
K),
nitrogen dioxide
(NO2
K)
Nitrous acid (HNO2), dinitrogen trioxide/tetroxide (N2O3/
N2O4), nitronium (nitryl) ion (NO2
+), peroxynitrite (ONOO
),
alkyl peroxynitrite (ROONO), nitroxyl anion (NO
), nitrosyl
cation (NO
+), nitryl chloride (NO2Cl)
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(Williams et al, 2004). A derivative of NO-ASA in which the NO-
donating moiety was substituted by diethylphosphate also induced
oxidative stress (Kashfi and Rigas, 2007; Sun Y, Rigas B,
unpublished data). Interestingly, this compound, provisionally
termed ‘phosphoaspirin’ is quite effective in preventing colon
cancer in a xenograft animal model (Rigas and Kozoni, 2008). This
finding emphasises that the oxidative stress induced by NO-ASA is
not due exclusively to the NO that it releases.
The specifics of this effect are currently unclear but its
mechanistic significance is unmistakable. It is quite likely that
many of the changes in the signalling pathways mentioned above
are derivative events, generated by redox changes that either lead
to reversible redox signalling or irreversible oxidative stress that
culminates in cell death and thus elimination of the neoplastic cell
(Figure 1).
ADDITIONAL EXAMPLES OF RONS-MEDIATED
CANCER PREVENTION: n–3 PUFA AND
CONVENTIONAL NSAIDs
Chapkin’s team, studying the impact of n–3 polyunsaturated fatty
acids (PUFA) (dietary fish oil) on colon carcinogenesis, showed
that n–3 PUFA inhibited carcinogenesis through modulation of
ROS levels. Several mechanistic findings supported this notion –
and underscored the complexity of the relevant phenomena. Fish
oil reduced oxidative DNA damage, lowered cell proliferation, and
increased apoptosis in rats, preventing colon cancer (Hong et al,
2005). Interestingly, n–3 PUFA induced apoptosis either alone
or synergistically when combined with butyrate (a product of
fermentable fibre). Apoptosis was associated with increased ROS
production and inhibition of antioxidant enzymes, such as SOD,
catalase, and GSH peroxidase (Sanders et al, 2004). Membrane
phospholipid hydroperoxides, one of the ROS (Sanders et al, 2004;
Ng et al, 2005), disrupted the mitochondrial permeability
transition pore and released cytochrome c into cytosol, triggering
apoptosis. n–3 PUFA induced oxidative damage not only of the
mitochondrial membrane but also of other membrane structures,
such as lipid rafts in plasma membrane, which play an important
role in the modulation and integration of cell signalling (Switzer
et al, 2004). Reactive oxygen species generation by these
chemopreventive interventions was the critical biochemical change
that appeared to precede a host of relevant signalling events.
Conventional NSAIDs provide another example of how RONS
may mediate cancer prevention. Epidemiological and interven-
tional studies have established that NSAIDs reduce the risk of
colon cancer and regress colorectal adenomas in patients with
familial adenomatous polyposis (Baron, 2003). Besides their
classical inhibitory effect on cyclooxygenase, NSAIDs exert
pleiotropic non-COX effects (Hanif et al, 1996), including the
generation of ROS. Although at times methodologically limited, the
relevant literature provides a consensus that treatment of various
cancer cell lines with NSAIDs does indeed generate increased ROS
levels.
Giardina and colleagues determined the effect of the NSAIDs
indomethacin and salicylic acid, and the short-chain fatty acids
butyrate and propionate on ROS metabolism in the HT-29 human
colorectal carcinoma cell line. All these agents increased cellular
peroxide generation. Interestingly, (a) these agents sensitised the
normally resistant HT-29 cells to TNF-a-induced apoptosis, and
(b) arachidonic acid, which also increased ROS, synergised with
indomethacin in this reaction (Giardina and Inan, 1998; Giardina
et al, 1999). The NSAID sulindac, and its derivatives sulindac
sulphide and sulindac sulphone increased RONS levels in DLD-1
colon cancer cells, assayed with a probe that reacts with several
such species (Oh et al, 2003; Adachi et al, 2007). Of note, these
three compounds had broader effects on redox homeostasis, as
they increased transiently the activity of catalase, SOD, and GSH
peroxidase. An antioxidant effect was also suggested by in vitro
studies assessing scavenging activity of sulindac and its derivatives
against various RONS (Fernandes et al, 2003; Costa et al, 2005). It
is, however, the balance of these antithetic events that determines
the final redox status and all evidence indicates it to be pro-
oxidant. A study by Chung et al (2003) demonstrated that sodium
salicylate mediates ROS production followed by decreased
mitochondrial membrane potential, release of cytochrome c, and
activation of caspase-9 and -3. Reactive oxygen species scavengers
and an inhibitor of NADPH oxidase as well as expression of a
dominant-negative form of Rac1 blocked ROS production and the
consequent apoptotic cell death.
Chemotherapeutic agents are also known to induce the
production of RONS. For example, the topoisomerase inhibitor
etoposide (Oh et al, 2007), arsenic trioxide (Nakagawa et al, 2002),
and cisplatin (Berndtsson et al, 2007) all induced cell death in
various cancers through oxidative stress.
CONCLUSIONS
Our data and those reported by others make it clear that an array
of agents controlling cancer either through prevention or
treatment have as their common denominator the production of
COO
OCOCH3
CH2ONO2
NO-ASA 
RONS 
Antioxidant 
Oxidative stress  RONS signalling 
p38, JNK, NF-B, COX-2,  
NOS, Wnt, Keap1-Nrf2 
Apoptosis/necrosis 
Cancer prevention 
Figure 1 Nitric oxide-donating aspirin, RONS, and cancer prevention.
Nitric oxide-donating aspirin induces cell death by altering the redox
balance. It achieves it by reducing the levels of cellular antioxidants, such as
GSH, and/or by generating RONS, such as superoxide anion, nitric oxide,
peroxynitrite, and hydrogen peroxide. The net effect is time and
concentration dependently increased RONS levels. Moderately elevated
levels of RONS initiate RONS signalling, such as through MAPKs (p38,
JNK), NF-kB, COX-2, NOS, Wnt, and Keap1-Nrf2, which can lead to
apoptotic cell death. Excessive RONS levels constitute oxidative stress,
which drives the cell directly to apoptosis or necrosis. The redox-mediated
cytokinetic effect of NO-ASA, which eliminates neoplastic cells, constitutes
perhaps its major chemopreventive action against cancer.
Oxidative stress and chemoprevention
B Rigas and Y Sun
1159
British Journal of Cancer (2008) 98(7), 1157–1160 & 2008 Cancer Research UKRONS. An additional point is equally clear: a significant fraction
of cell signalling pathways modulated by these agents is RONS
dependent or RONS responsive; activation of such pathways
culminates to the death of the relevant cell through either
apoptosis or its variants or through necrosis (Heck et al, 2005).
That the chemopreventive agents discussed here work by
increasing RONS levels suggests that modulation of redox
biochemistry represents a fruitful approach to cancer prevention.
Conceptualising this underappreciated target for cancer control
should guide efforts to develop novel agents or combinations
thereof, in which RONS levels are the guiding read-out. This
approach illustrates how mechanistic understanding of the
pharmacological mode of action of effective agents can be
translated into an effective chemoprevention strategy.
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